Please wait
0001590750Viridian Therapeutics, Inc.\DE333-267351S-3424B5EX-FILING FEESCommon Stock, par value $0.01 per shareSeries B Non-Voting Preferred Stock, par value $0.01 per share 0001590750 2024-09-12 2024-09-12 0001590750 1 2024-09-12 2024-09-12 0001590750 2 2024-09-12 2024-09-12 iso4217:USD xbrli:pure xbrli:shares
Exhibit 107
Calculation of Filing Fee Tables
424(b)(5)
(Form Type)
Viridian Therapeutics, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
 
                 
     Security
Type		  
Security
Class
Title
   Fee
Calculation
or Carry
Forward
Rule		   Amount
Registered		   Proposed
Maximum
Offering
Price Per
Unit		  
Maximum
Aggregate
Offering
Price
  
Fee
Rate
   Amount of
Registration
Fee
 
Newly Registered Securities
                 
Fees to
Be Paid
   Equity   
Common Stock, par 
value $0.01 per share
   457(r)    12,466,600(1)    $18.75    $233,748,750.00    0.00014760    $34,501.32
                 
Fees to
Be Paid
   Equity   
Series B Non-Voting 
Preferred Stock, par 
value $0.01 per share 
   457(r)    20,000    $1,250.06250    $25,001,250.00    0.00014760    $3,690.19
                 
Fees
Previously
Paid
   —    —    —    —    —    —      —
 
Carry Forward Securities
                 
Carry
Forward
Securities
   —    —    —    —      —     
 
           
 
   Total Offering Amounts      $258,750,000.00      $38,191.51
           
 
   Total Fees Previously Paid          —
           
 
   Total Fee Offsets          —
           
 
   Net Fee Due   
 
  
 
  
 
   $38,191.51
 
(1)
Assumes exercise in full of the underwriters’ option to purchase up to 1,800,000 additional shares of common stock.